SN-38-D3
CAS No. 718612-49-8
SN-38-D3 ( 7-乙基-10-羟基喜树 )
产品货号. M39327 CAS No. 718612-49-8
SN-38-d3 是 SN-38 的氘代物。SN-38 (NK012) 是拓扑异构酶 I (Topoisomerase I) 抑制剂伊立替康的活性代谢产物。SN-38 (NK012) 抑制 DNA 合成和 RNA合成的 IC50 分别为 0.077 和 1.3 μM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥41610 | 有现货 |
|
| 10MG | ¥56240 | 有现货 |
|
| 25MG | ¥91791 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SN-38-D3
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SN-38-d3 是 SN-38 的氘代物。SN-38 (NK012) 是拓扑异构酶 I (Topoisomerase I) 抑制剂伊立替康的活性代谢产物。SN-38 (NK012) 抑制 DNA 合成和 RNA合成的 IC50 分别为 0.077 和 1.3 μM。
-
产品描述SN-38-d3 is the deuterium labeled SN-38. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively.
-
体外实验———
-
体内实验Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
-
同义词7-乙基-10-羟基喜树
-
通路Others
-
靶点Other Targets
-
受体———
-
研究领域———
-
适应症———
化学信息
-
CAS Number718612-49-8
-
分子量395.42
-
分子式C22H20N2O5
-
纯度>98% (HPLC)
-
溶解度DMSO : 25 mg/mL (63.22 mM; ultraphonic; )
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. ?
产品手册
关联产品
-
α1 adrenoceptor-MO-1
α1 adrenoceptor-MO-1 是一种 S 型对映体,对 alpha 1 adrenergic receptor 具有亲和性,可以抗 α-肾上腺素能,同时能够止痛;比 R 型对映体的活性高。
-
APL1β27 trifluoroace...
APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)
-
3-Hydroxybakuchiol
3-Hydroxybakuchiol exerts cytotoxic and anti-proliferative effects on the TA3/Ha mouse mammary adenocarcinoma cell line and induces a decrease in the mitochondrial transmembrane potential, the activation of caspase-3, the opening of the mitochondrial permeability transport pore (MPTP) and nuclear DNA fragmentation.3-Hydroxybakuchiol has antitumor activity resulting from interactions with the ETC, a system that is already deficient in cancer cells.
021-51111890
购物车()
sales@molnova.cn

